Sio Capital Management LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management LLC | 2,636,548 4.980% | -1,098,848 (-29.42%) | Filing |
| 2025-08-13 2:00 pm Unchanged | 2025-06-30 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management LLC | 3,735,396 7.190% | 0 (Unchanged) | Filing |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management LLC | 3,735,396 7.190% | 163,229 (+4.57%) | Filing |
| 2025-02-10 12:58 pm Purchase | 2024-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Sio Capital Management LLC | 3,572,167 6.900% | 3,572,167 (New Position) | Filing |